USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Global Single Cell Genomics and Proteomics Market, Forecast to 2023
Clinical Applications for Single Cell Analysis Remain a Heavily Uncontested Market Place
03-Sep-2019
North America
Market Research
Single cell genomic and proteomics tools have gained significant importance in the past 2 years. The year 2018 was particularly very active with a lot of platforms made available by both established life sciences tools companies and start-ups. 10X Genomics and Fluidigm have demonstrated the potential for high-throughput single cell applications. There is a constant quest for delivering the lowest cost per cell which is keeping the innovation curve high. Single cell technology developers continue to attract funds from venture capitalists, making it one of the attractive areas to invest in the life science industry. While advancements in the hardware side are addressing throughput and low cost per cell, complexity in the data analysis remains unaddressed, which leaves opportunities to develop analytical tools and bioinformatics pipeline for single cell analysis data. From an application standpoint, while most of the current applications for single cell analysis are restricted to translational research, biopharma applications present the second largest opportunity. Single cell analysis for clinical applications is a long-term opportunity and the company that focuses more on addressing this application will clearly gain the first-mover advantage.
This study analysis the global single cell genomic and proteomic technologies and workflows and identifies key application areas and concepts that can help companies steer their way toward running a successful business. Documented insights from single cell biologists and researchers have been studied to identify current and future applications across translational, biopharma, clinical, and basic research. The study covers an assessment of the market across workflows, technologies, geographic regions and applications. These assessments have been developed after carefully studying 23 companies that are currently offering and developing solutions for single cell isolation and analytical purposes.
Key Issues Addressed
- What is the future outlook for single cell technologies?
- What specific applications offer growth opportunities that can be leveraged by existing and future participants?
- What are the unmet needs and challenges in the single cell genomics and proteomics industry?
- What types of technologies (e.g., droplet based) are poised for growth?
- Who are the major companies offering high-, moderate-, and low-throughput solutions?
- What applications are driving the update of single cell genomic technologies?
- What are the strengths of companies offering single cell genomic and proteomic technologies?
- How will the structure of the market change over time? Is it ripe for acquisitions?
- How has the industry M&A evolved between various companies offering single cell genomics solutions?
- Where are the major themes of partnership?
- Who are the right customers/target audience for platforms?
- What do they want? What are they willing to pay?
- Did you mean to say ‘uptake’ here? Please check.
Author: Divyaa Ravishankar
Key Findings
Key Findings (continued)
Scope and Segmentation
Key Questions this Study will Answer
Market Drivers
Market Restraints
Market Drivers and Restraints (continued)
Interest in Single Cell Genomics
Research Areas of Interest in Single Cell Analysis
Comparison of Traditional Cell Isolation Techniques
Analyst’s Take on Established Companies
Analyst’s Take on Established Companies (continued)
Analyst’s Take on Established Companies (continued)
Key Technologies and Workflow—Competitor Landscape
Single Cell Analysis Workflow Technology
Single Cell Analysis Workflow Technology (continued)
Single Cell Analysis Workflow Technology (continued)
Single Cell Analysis Workflow Technology (continued)
Early-Stage Company Funding Trends for Single Cell Analysis
Early-Stage Company Funding Trends for Single Cell Analysis (continued)
U.S Research Center Funding Trends
U.S Research Center Funding (Y-o-Y) Analysis
Commercial Funding
SCG Cores Around the World
Key Partnerships
Key Partnerships (continued)
Shift towards High-Throughput Platforms
Increased Focus on Computational Tools
Emergence of New Applications for SCG
Strategic Imperatives for Success and Growth
Mission Bio Gains the First-mover Advantage as the Only DNA Isolation Platform
The Only Renowned Platform in the Market for High-throughput Single Cell Analysis
While Seen as an Industry Standard for Single Cell Analysis, New Competitors can Weaken Fluidigm’s Market Position
UK-based Company Set Out to Provide Competition to Existing Single Cell Companies
When Combined with Veridex CTC Cell Search Deparray, the Company’s Solution Proves its Potential in the Clinical Setting
Commercially Launched in December 2018, 1CellBio Aims to Tap into Machine Learning to Identify Patterns of Gene Expression in Single Cells
Single Cell Genomics and Proteomics Market—Revenue Forecast
Single Cell Genomics and Proteomics Market—Revenue Forecast by Application
Revenue Breakdown by Technology and Workflow
Challenges with Single Cell Analysis Workflows
Challenges
Future Applications and Use Cases
Future Applications and Use Cases (continued)
Key Conclusions and Future Outlook
Legal Disclaimer
Computational Tools
Computational Tools (continued)
List of Companies Mentioned in this Report
List of Exhibits
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Key Issues Addressed
- What is the future outlook for single cell technologies
- What specific applications offer growth opportunities that can be leveraged by existing and future participants
- What are the unmet needs and challenges in the single cell genomics and proteomics industry
- What types of technologies (e.g., droplet based) are poised for growth
- Who are the major companies offering high-, moderate-, and low-throughput solutions
- What applications are driving the update of single cell genomic technologies
- What are the strengths of companies offering single cell genomic and proteomic technologies
- How will the structure of the market change over time Is it ripe for acquisitions
- How has the industry M&A evolved between various companies offering single cell genomics solutions
- Where are the major themes of partnership
- Who are the right customers/target audience for platforms
- What do they want What are they willing to pay
- Did you mean to say ‘uptake’ here Please check.
Author: Divyaa Ravishankar
| Deliverable Type | Market Research |
|---|---|
| Author | Divyaa Ravishankar |
| GPS Codes | 9600-B1,9562-B1,9571-B1,9573-B1,99C1-B1,99C6-B1,9837-B1,9568-B1,9611-B1,9627-B1 |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Podcast | No |
| WIP Number | 9AB9-00-B9-00-00 |